Analyst Price Targets — TMO
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| July 6, 2026 12:48 pm | — | Evercore ISI | $570.00 | $511.31 | TheFly | Thermo Fisher price target lowered to $570 from $575 at Evercore ISI |
| June 26, 2026 10:26 am | — | Bernstein | $520.00 | $505.75 | TheFly | Thermo Fisher resumed with a Market Perform at Bernstein |
| June 11, 2026 9:52 am | — | Piper Sandler | $510.00 | $482.04 | TheFly | Thermo Fisher initiated with a Neutral at Piper Sandler |
| June 3, 2026 7:12 am | Sidharth Sahoo | HSBC | $540.00 | $482.08 | StreetInsider | HSBC Downgrades Thermo Fisher Scientific (TMO) to Hold |
| May 14, 2026 8:21 pm | — | RBC Capital | $490.00 | $448.21 | TheFly | Thermo Fisher resumed with a Sector Perform at RBC Capital |
| April 27, 2026 12:33 pm | Kallum Titchmarsh | Morgan Stanley | $620.00 | $472.23 | TheFly | Thermo Fisher price target lowered to $620 from $670 at Morgan Stanley |
| April 24, 2026 12:16 pm | Daniel Arias | Stifel Nicolaus | $600.00 | $467.47 | TheFly | Thermo Fisher price target lowered to $600 from $700 at Stifel |
| April 24, 2026 10:34 am | Catherine Ramsey Schulte | Robert W. Baird | $639.00 | $466.70 | TheFly | Thermo Fisher price target lowered to $639 from $653 at Baird |
| January 30, 2026 2:25 pm | — | UBS | $615.00 | $579.86 | TheFly | Thermo Fisher price target raised to $615 from $590 at UBS |
| January 30, 2026 2:08 pm | — | Wells Fargo | $683.00 | $580.09 | StreetInsider | Thermo Fisher Scientific (TMO) PT Lowered to $683 at TD Cowen |
Latest News for TMO
TMO readies for second-quarter 2026 earnings, with growth expected across key segments as bioproduction, clinical research and new launches support results.
On July 13, 2026, we present a detailed DCF analysis for Thermo Fisher Scientific Inc (TMO), a company currently priced at $527.05. Despite a year-to-date decli
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its Board of Directors authorized a quarterly cash dividend of $0.47 per common share, payable on October 15, 2026, to shareholders of record as of September 15, 2026. About Thermo Fisher Scientific Thermo Fisher Scientific Inc. is the world leader in serving science, with annual…
Thermo Fisher Scientific Inc. is down 12.2% YTD, underperforming both the S&P 500 and the healthcare sector. Key risks include NIH funding uncertainty, China weakness, slow organic recovery, and integration risk from the $8.9B Clario acquisition. TMO trades at an 18% discount to its 5-year average P/E, reflecting much of the downside already priced in.
SAN FRANCISCO--(BUSINESS WIRE)--Thermo Fisher Scientific, the world leader in serving science, today announced that the Applied Biosystems™ RapidINTEL™ Plus Cartridge has received approval from the Federal Bureau of Investigation (FBI) National DNA Index System (NDIS) for use with qualifying forensic crime scene samples. The law enforcement milestone makes Thermo Fisher's Rapid DNA workflow on the RapidHIT ID™…
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
Senate Trading Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.